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Natural History of Left Ventricular Mechanics in
Transplanted Hearts
Relationships With Clinical Variables and Genetic Expression Proﬁles of
Allograft Rejection
Mackram F. Eleid, MD, Giuseppe Caracciolo, MD, Eun Joo Cho, MD,
Robert L. Scott, MD, D. Eric Steidley, MD, Susan Wilansky, MD,
Francisco A. Arabia, MD, Bijoy K. Khandheria, MD, Partho P. Sengupta, MD, DM
Scottsdale, Arizona
O B J E C T I V E S The aim of this study was to explore the temporal evolution of left ventricular (LV)
mechanics in relation to clinical variables and genetic expression proﬁles implicated in cardiac allograft
function.
B A C KG ROUND Considerable uncertainty exists regarding the range and determinants of variabil-
ity in LV systolic performance in transplanted hearts (TXH).
METHOD S Fifty-one patients (mean age 53  12 years; 37 men) underwent serial assessment of
echocardiograms, cardiac catheterization, gene expression proﬁles, and endomyocardial biopsy data
within 2 weeks and at 3, 6, 12, and 24 months after transplantation. Two-dimensional speckle-tracking
data were compared between patients with TXH and 37 controls (including 12 post–coronary artery
bypass patients). Post-transplantation mortality and hospitalizations were recorded with a median
follow-up period of 944 days.
R E S U L T S Global longitudinal strain (LS) and radial strain remained attenuated in patients with TXH
at all time points (p  0.001 and p  0.005), independent of clinical rejection episodes. Failure to
improve global LS at 3 months (1 SD) was associated with higher incidence of death and cardiac
events (hazard ratio: 5.92; 95% conﬁdence interval: 1.96 to 17.91; p  0.049). Multivariate analysis
revealed gene expression score as the only independent predictor of global LS (R2  0.53, p  0.005),
with SEMA7A gene expression having the highest correlation with global LS (r  0.84, p  0.001).
CONC L U S I O N S Speckle tracking–derived LV strains are helpful in estimating the burden of LV
dysfunction in patients with TXH that evolves independent of biopsy-detected cellular rejection. Failure
to improve global LS at 3 months after transplantation is associated with a higher incidence of death and
cardiac events. Serial changes in LV mechanics correlate with peripheral blood gene expression proﬁles
and may affect the clinical assessment of long-term prognosis in patients with TXH. (J Am Coll Cardiol
Img 2010;3:989–1000) © 2010 by the American College of Cardiology Foundation
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990eart transplantation is an effective therapy
for patients with end-stage heart failure,
with 1-year post-transplantation survival
approaching 90% (1). However, most grafts
uccumb slowly over time, with only 50% of pa-
ients surviving at 10 years. Although cardiac re-
ransplantation remains a therapeutic option, the
vailability of donor hearts remains limited, and the
uccess of cardiac retransplantation depends on
he duration of survival of the first allograft (2).
tandard measures of left ventricular (LV) systolic
unction, such as ejection fraction and volumes, are
ommonly used to monitor graft function, but tend
o be stable over time and do not correlate with
iopsy-proven rejection or time after transplanta-
ion (3). The assessment of LV strain by speckle
racking has recently emerged as an angle-
ndependent, noninvasive variable for characteriz-
ng regional and global LV function from routinely
cquired grayscale cardiac ultrasound images (4,5),
nd shows excellent correlation with LV strain
easured by sonomicrometry and cardiac magnetic
resonance (6 – 8). Although speckle-
tracking strain has been used in a growing
number of clinical situations (9), its utility
in the serial assessment of LV mechanical
function in transplanted hearts remains
uncertain.
Considerable uncertainty exists regard-
ing the range and prognostic significance
of the LV ejection fraction in transplanted
hearts (TXH) (10–13). Factors that deter-
ine LV function in the post-transplantation set-
ing include the alloimmune response, development
f transplant vasculopathy, and a variety of nonim-
une risk factors such as post-surgical sympathetic
enervation, hyperlipidemia, hypertension, diabetes
ellitus, hyperhomocysteinemia, advancing age,
ost-transplantation infections, and donor variables
ncluding age, LV hypertrophy, and gender mis-
atch (1,14–19). The use of gene expression pro-
ling of peripheral blood specimens for character-
zing host immune responses (20) in combination
ith clinical and echocardiographic assessments of
V function has been suggested as a conservative
pproach to the care of heart transplant recipients
21). However, there is little information to link
linical variables and genetic expression profiles
ith serial changes in LV function seen in patients
ith TXH.
The goals of this study were to: 1) understand the
emporal evolution of LV longitudinal, circumfer-
lential, and radial mechanics as a marker of graft tunction in patients with TXH; and 2) identify a
otential link between gene expression profiles and
erial changes in LV mechanics for characterizing
he role of chronic immune and inflammatory
ctivation in cardiac allograft dysfunction.
ETHODS
he Mayo Clinic Institutional Review Board ap-
roved this study. Between October 20, 2005, and
eptember 18, 2008, 51 consecutive patients (mean
ge 53  12 years; 37 men) who underwent heart
ransplantation at our institution were enrolled in
he study. Serial clinical and 2-dimensional (2D)
chocardiographic data were obtained at 2 weeks
nd at 3, 6, 12, and 24 months in 45, 48, 44, 31, and
patients, respectively, after transplantation. Clin-
cal data including demographics, comorbid condi-
ions, laboratory results, cardiac events, rehospital-
zation, and death were recorded for each patient.
ardiac events were defined as episodes of heart
ailure, rejection, or acute coronary syndromes re-
uiring hospitalization. Hospitalizations, cardiac
vents, and all-cause mortality were recorded from
he start of enrollment (October 20, 2005) through
pril 25, 2010. The median length of follow-up
as 944 days.
Twenty-five healthy subjects with similar age and
ender to the study population (mean age 47  15
ears; 12 men) who had normal echocardiographic
esults served as controls. To compare post-
perative LV mechanics in patients with TXH with
hose of nontransplanted post–cardiac surgery pa-
ients, 12 patients with normal LV function under-
oing coronary artery bypass surgery at our institu-
ion (mean age 53  9 years; 9 men) had LV
echanics analyzed on echocardiography at least 1
onth (mean 125 119 days) after their surgery to
erve as post-operative controls.
D echocardiography. Echocardiographic studies
ere performed on commercially available ultra-
ound equipment (Acuson Sequoia, Siemens Med-
cal Solutions USA, Mountain View, California;
nd Vivid 7, GE Healthcare, Milwaukee, Wiscon-
in) according to the standard method recom-
ended by the American Society of Echocardiog-
aphy (22), and digital images were obtained at
ptimal frame rates (30 frames/s). Images were
tored in digital cine loop format (ProSolv Cardio-
ascular Solutions, Indianapolis, Indiana) for offline
nalysis by vendor-customized 2D Cardiac Perfor-
ance Analysis software (TomTec Imaging Sys-B B R E V I A T I O N S
N D A C R O N YM S
S circumferential strain
S longitudinal strain
V left ventricular/ventric
S radial strainems, Munich, Germany).
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9912D Cardiac Performance Analysis is a speckle
racking–based analysis tool that is an extension of
elocity Vector Imaging software (Siemens Medi-
al Systems, Erlangen, Germany), which has been
reviously validated with sonomicrometry (8,23)
nd magnetic resonance imaging (24,25). 2D Car-
iac Performance Analysis, similar to Velocity Vec-
or Imaging, determines myocardial motion from a
ser-defined tracing along the endocardial border.
oth user-defined endocardial and automated sub-
picardial borders are traced throughout 1 cardiac
ycle for calculating myocardial velocity, longitudi-
al strain (LS), and radial strain (RS) for both
ndocardial and subepicardial regions.
LS from endocardial and subepicardial regions
as obtained from 6 LV segments in apical
-chamber views. Circumferential strain (CS) and
S were obtained from 6 segments in short-axis
iews of the left ventricle at the level of the papillary
uscle. In addition to strains obtained at the
egmental level, we also calculated global LS, CS,
nd RS as an average of strain values obtained from
he 6 segments in respective views. Assessment of
V strain was regarded as suboptimal when either:
) speckle tracking could not be obtained for at least
of the 6 myocardial segments in apical 4-chamber
r short-axis views; or 2) a theoretically unaccept-
ble value or values were obtained.
eripheral blood mononuclear cell gene expression
nalysis. At approximately 1-month intervals after
ransplantation, whole venous blood in 8-ml ali-
uots from each subject was transferred into a
acutainer CPT Cell Preparation Tube (Becton
ickinson, Franklin Lakes, New Jersey) with so-
ium citrate. Peripheral blood mononuclear cells
ere then isolated using density gradient centrifu-
ation and frozen in lysis buffer within 2 h of
hlebotomy. These samples were sent to XDx, a
linical Laboratory Improvement Amendments–
ertified laboratory in Brisbane, California, where
ibonucleic acid was subsequently purified from the
eripheral blood mononuclear cell lysate. Using
eal-time polymerase chain reaction, cell messenger
ibonucleic acid cycle threshold levels of 20 genes
ere evaluated, including 11 genes representing
ultiple diverse molecular pathways (IL1R2,
LT3, ITGAM, ITGA4, PF4, C6orf25, PDCD1,
IR, WDR40A, SEMA7A, and RHOU) and 9
ontrol genes used for reproducibility and standard-
zation (26). Cycle threshold levels were then inte-
rated into a cumulative gene expression score on a
cale of 0 to 40 for each sample (19,26).tatistical analysis. All continuous data are reported
s mean  SD and categorical data as percentages.
tudent t test was used for comparisons of contin-
ous variables between patients with histories of
ejection and nonrejection. One-way analysis of
ariance with the post hoc Scheffé test was used for
arametric comparisons of measurements obtained
ithin 2 weeks and 3, 6, 12, and 24 months after
ransplantation. Pearson correlation coefficient was
sed to reveal relations between 2 continuous vari-
bles. Univariate simple linear regression was used
o compare clinical variables with the outcome of
veraged global LS at 1 year. Multiple linear regres-
ion analysis was used to evaluate the relationship
etween averaged endocardial and epicardial LS at
2 months and various clinical and echocardio-
raphic variables showing significant correlations
p  0.10) using commercially available software
SPSS version 12.0, SPSS, Inc., Chicago, Illinois).
mprovement in strain at 3 months was defined as a
1-SD change in global LS assessed at the first
ost-transplantation echocardiographic study (27–29).
vent rates for death, hospitalizations, and cardiac
vents were calculated by dividing the total number
f events by the number of patient-years and
ompared using Poisson distribution. Survival anal-
sis was performed using the Kaplan-Meier
ethod. Mortality curves were generated separately
or patients with and without improvement in
lobal LS and then compared using the log-rank
est. Interobserver and intraobserver variability was
alculated as the absolute difference of the corre-
ponding pair of repeated measurements in percent
Table 1. Cardiac Transplantation Patient Characteristics at
Enrollment (n  51)
Variable Value
Age (yrs) 52.6 12.9
Men 38 (75%)
Diabetes mellitus 19 (37%)
Hypertension 23 (45%)
Hyperlipidemia 29 (57%)
Obstructive sleep apnea 12 (24%)
Heart failure etiology
Ischemic 25 (49%)
Idiopathic 22 (43%)
Other* 4 (8%)
Body mass index (kg/m2) 26.8 5.0
Creatinine (mg/dl) 1.1 0.5
B-type natriuretic peptide (mg/dl) 688.6 502.9
Data are expressed as mean SD or as n (%). *One patient with anthracycline
toxicity and 3 with valvular cardiomyopathy.
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992f their mean in each patient and then averaged for
8 randomly selected patients. A p value0.05 was
onsidered statistically significant.
E SULTS
he clinical and echocardiographic characteristics
f cardiac transplantation patients at baseline are
hown in Table 1. Of 51 transplant recipients, 18
35%) experienced 1 or more episodes of biopsy-
roven International Society for Heart and Lung
ransplantation grade 2R or higher acute cellular
ejection (30) in the first year. Differences in clinical
nd echocardiographic variables in patients who
xperienced 1 or more episodes of International
ociety for Heart and Lung Transplantation grade
R or higher acute cellular rejection versus those
ho did not have rejection at completion of 1 year
re shown in Tables 2 to 4. Coronary allograft
asculopathy at 1 year after transplantation was seen
n 13 patients (25%). Six patients died during the
tudy period at 78, 87, 222, 296, 448, and 896 days
nsplantation Patient Characteristics at 1-Year Follow-Up
Rejection
(n  13)
No Rejection
(n  18) p Value
47.8 14.6 58.6 5.5 0.02
6 (46.2%) 9 (50%) 0.83
3 (23.1%) 8 (44.4%) 0.40
8 (61.5%) 12 (66.7%) 0.77
ea 2 (15.4%) 7 (38.9%) 0.16
n (kg/m2) 25.7 5.4 27.3 4.8 0.39
25.7 5.8 28.8 5.3 0.15
n (pg/ml) 965.9 674.5 563.7 385.7 0.07
130.3 96.8 100.9 53.6 0.34
(mg/dl) 1.0 0.5 1.2 0.7 0.45
1.2 0.3 1.4 0.4 0.12
171 40 208 51 0.03
8 (61.5%) 14 (77.8%) 0.33
6 (46.2%) 4 (22.2%) 0.16
sion score 27.3 4.1 26.7 5.0 0.69
(beats/min) 91 10 91 15 0.89
) 101 12 91 8 0.02
(mm Hg) 123 13 130 13 0.12
121 15 130 13 0.10
12.2 3.8 13.8 8.2 0.48
ejection 12.4 5.4 — —
15.0 6.4 17.9 7.7 0.29
rejection 21.0 9.3 — —
10.6 4.9 12.3 14.1 0.64
rejection 9.3 6.6 — —
ean  SD or as n (%).
x; BNP  B-type natriuretic peptide; CAV  coronary allograft vasculopathy;
; CMV  cytomegalovirus; Cr  creatinine; CS  circumferential strain; HR 
longitudinal strain; RS  radial strain; SBP  systolic blood pressure.fter transplantation. Primary causes of death in
hese patients, respectively, were pseudomonas
neumonia, primary graft failure, massive myocar-
ial infarction with invasive aspergillosis, Clostrid-
um difficile colitis with renal failure, end-stage liver
isease due to hepatitis C, and coronary allograft
Table 3. 2-Dimensional Echocardiographic and Doppler Data
at 1 Year
Variable
Rejection
(n  13)
No Rejection
(n  18) p Value
IVSd (mm) 12.6 2.6 11.6 2.0 0.20
LVPWd (mm) 11.6 2.0 10.8 1.3 0.20
LVDd (mm) 44.4 4.3 43.9 4.0 0.70
LVDs 29.5 4.8 26.8 3.2 0.10
EF (%) 59.3 9.5 61.9 7.7 0.40
LV mass (g) 187.1 57.7 171.5 40.5 0.50
LAVI 40.9 12.3 47.9 10.3 0.30
E (cm/s) 0.8 0.2 0.9 0.3 0.40
A (cm/s) 0.5 0.2 0.4 0.2 0.80
E/A 1.8 0.5 2.1 0.7 0.30
DT (s) 153.2 23.8 172 20.2 0.10
IVRT (s) 82.4 19.9 92.3 21.1 0.30
E= medial (m/s) 0.1 0.0 0.1 0.0 0.10
E= lateral (m/s) 0.1 0.0 0.1 0.0 0.60
E/E= medial 8.3 3.1 12.7 8.4 0.10
E/E= lateral 7.1 2.5 7.6 4.0 0.70
SV (cm3) 59.4 11.2 66.3 12.3 0.10
CO (l/min) 5.8 1.4 6.0 1.3 0.70
RVSP (mm Hg) 29.9 7.8 31.6 6.7 0.60
RAP (mm Hg) 6.7 3.3 5.8 1.9 0.40
TR peak velocity (m/s) 2.4 0.3 2.5 0.3 0.20
TV MIG (mm Hg) 23.3 6.1 26.3 5.9 0.20
Data are expressed as mean  SD.
A  late diastolic mitral inﬂow velocity; CO  cardiac output; DT 
deceleration time; E  early diastolic mitral inﬂow velocity; E=  mitral
annular diastolic velocity; EF ejection fraction; IVRT isovolumic relaxation
time; IVSd  interventricular septal thickness; LAVI  left atrial volume index;
LS  endocardial longitudinal strain; LV  left ventricular; LVDd  diastolic
left ventricular dimension; LVDs  systolic left ventricular dimension; LVPWd
 left ventricular posterior wall thickness; MIG  maximum instantaneous
gradient; RAP  right atrial pressure; RVSP  right ventricular systolic
pressure; SV  stroke volume; TR  tricuspid regurgitation; TV  tricuspid
valve.
Table 4. Right-Heart Hemodynamic Data at 1-Year Follow-Up
Variable
Rejection
(n  13)
No Rejection
(n  18) p Value
RAP (mm Hg) 8.7 4.3 6.8 3.3 0.20
RVSP (mm Hg) 29.5 4.7 30.6 7.1 0.60
PCWP (mm Hg) 13.1 6.6 10.6 5.1 0.40
SVO2 62.4 9.0 63.5 4.7 0.80
CO (l/min) 5.2 1.8 5.1 1.2 0.90
CI (l/min/m2) 2.5 0.7 2.6 0.6 0.80
Data are expressed as mean  SD.
CI  cardiac index; PCWP  pulmonary capillary wedge pressure; SVO2 Table 2. Cardiac Tra
Variable
Age (yrs)
Hypertension
Diabetes mellitus
Hyperlipidemia
Obstructive sleep apn
BMI at transplantatio
BMI at 1 yr (kg/m2)
BNP at transplantatio
BNP at 1 yr (pg/ml)
Cr at transplantation
Cr at 1 yr (mg/dl)
CIT (min)
CMV positive
CAV at 1 yr
Average gene expres
HR at transplantation
HR at 1 yr (beats/min
SBP at transplantation
SBP at 1 yr (mm Hg)
Global LS at 1 yr
Global LS at time of r
Global CS at 1 yr
Global CS at time of
Global RS at 1 yr
Global RS at time of
Data are expressed as m
BMI  body mass inde
CIT  cold ischemic timemixed venous oxygen saturation. Other abbreviations as in Table 3.
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993asculopathy. A total of 36 cardiovascular events
nd 117 hospitalizations occurred.
V mechanics. Serial assessment of LV mechanics
y speckle-tracking echocardiography was feasible
n 42 of 48 patients (88%) at 3 months, 43 of 44
98%) at 6 months, 30 of 31 (97%) at 1 year, and 6
f 7 (86%) at 2 years.
lobal strains. In comparison with controls, global
ndocardial LS and RS were markedly attenuated
n patients with TXH, irrespective of the presence
f early biopsy-detected rejection throughout the
tudy period (Fig. 1). Persistent abnormalities in
lobal LS (1-SD increase in global LS) were seen
n 31 of 42 patients (74%) at 3 months, in 34 of 43
79%) at 6 months, and in 24 of 29 (83%) at the end
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Figure 1. Natural History of LV Mechanics in Patients With Tran
Temporal evolution of endocardial longitudinal strain (LS-endo) (A),
strain (CS-endo) (C), epicardial circumferential strain (CS-epi) (D), an
tion measured at 2 weeks and 3, 6, 12, and 24 months after transp
tently reduced longitudinal strain throughout the study period com
grafting.f 1 year. Endocardial and epicardial CS and RS
emained unchanged at all intervals of follow-up
14.9% vs. 18.4%, p  0.10, and 6.0% vs.
6.4%, p  0.64, respectively).
Global LS, RS, and CS at the time of rejection
ere no different than in patients who did not
xperience rejection (Table 2). Furthermore, global
S and RS remained equally attenuated in both
roups on serial follow-up (Fig. 1). Decreased
ndocardial CS was observed at 2 years in subjects
ho experienced allograft rejection compared with
hose who did not (24.9  7.9 vs. 12.6  4.1,
 0.045) (Fig. 1).
egmental strains. In comparison with controls,
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994ost–coronary artery bypass patients. Both groups,
owever, showed higher regional strains at the LV
pex than at the LV base. In contrast, LV strains in
atients with TXH were attenuated in all 3 seg-
ents in comparison with controls (p  0.015, p 
.001, and p 0.001 for the basal, mid-, and apical
egments, respectively). On paired analysis, LS
emained persistently attenuated at the LV apex at
Base
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Figure 2. Regional Heterogeneity in LV Mechanics: LS in Patien
Longitudinal strain (LS) was equally reduced among all segments a
of 1 year, with no signiﬁcant changes in the mid- and apical segme
planted hearts (TXH) in comparison with both healthy and post–co
and p  0.001 for the basal, mid-, and apical segments for TXH vs.
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Both the patient with a heart transplant (TXH) 2 weeks after transp
experienced attenuation of basal segmental longitudinal strain (LS).
improvement of basal LS.year (Figs. 2 and 3), independent of episodes of
ejection.
S and clinical outcomes. A Kaplan-Meier curve for
eath and/or cardiovascular events for 11 patients
26%) with improvements in global LS and 31
atients (74%) who did not show improvements in
lobal LS within the first 3 months of transplant is
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995he first 3 months of transplantation was associated
ith a higher combined risk for death and hospi-
alization for heart failure or biopsy-detected rejec-
ion compared with those who showed improve-
ents in LS (1 SD; hazard ratio: 5.92; 95%
onfidence interval: 1.96 to 17.91; p  0.049) and
higher hospitalization rate (event rate: 1.13 vs.
.27 per patient-year, p  0.01).
eterminants of persistent LV dysfunction at 1
ear. Forty-five clinical variables were entered into
univariate simple linear regression with outcome
veraged global LS at 1 year. Seven variables
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Figure 4. SEMA7A Gene Expression and Relationship With
Global LS
Peak averaged endocardial and epicardial longitudinal strain (LS)
and correlation with gene expression score (AlloMap) averaged
over the ﬁrst year after transplantation (A) in patients with per-
sistent abnormalities in global LS (n  24). Lower cycle thresh-
old levels of SEMA7A (increasing gene expression) correlated
with higher averaged global LS (B).howed significance or trends toward significance iTable 5). A higher gene expression score was
ignificantly associated with higher LS averaged
rom endocardial and epicardial regions (R0.7,
 0.001) (Fig. 4).
After multivariate analysis, only the gene expres-
ion score averaged over 1 year showed a significant
elationship with global averaged LS (R2  0.53,
 0.005) (Table 5). A trend toward a significant
elationship was observed between LV mass and
lobal LS at 12 months. There was no significant
orrelation between averaged global LS at 1 year in
omparison with endomyocardial biopsy results,
ight-heart catheterization data, the presence of
oronary allograft vasculopathy, body mass index,
erum creatinine, and B-type natriuretic peptide at
ransplantation and 1 year.
eripheral blood gene expression analysis. To further
haracterize the origin of the relationship between
lobal LS and the gene expression score, each
pecific gene subcomponent of the gene expression
rofile was analyzed in comparison with averaged
lobal LS at 1 year (Table 6). The highest correla-
ion was with the SEMA7A gene (r  0.84, p 
.001). With increased expression (lower cycle
hreshold) of SEMA7A, heart transplantation recip-
ents had increasing LS (Fig. 4).
nterobserver and intraobserver variability. The abso-
ute intraobserver differences for endocardial LS,
picardial LS, endocardial CS, and epicardial CS
nd RS were 0.6  2.2%, 0.1  1.6%, 2.5  2.1%,
.2  1.7%, and 8.3  7.8%, respectively, and the
orresponding intraobserver variability were calcu-
ated as 10  7%, 8  7%, 11  10%, 25  22%,
nd 24  20%. The absolute interobserver differ-
nces for each measurement were 2.5  1.3%,
.9  1.2%, 3.5  2.9%, 2.2  1.7%, and 9.1 
.6%, respectively, and the corresponding interob-
erver variability were calculated as 13.6  6.3%,
12.6  7.9%, 16  15%, 26  21%, and 28 
9%, respectively.
I SCUS S ION
o the best of our knowledge, this is the first study
o describe the serial changes of LV mechanics in
atients with TXH using speckle-tracking strain
maging. Our data support the use of strain imaging
or assessing the burden of LV dysfunction that
volves in patients with TXH independent of
iopsy-detected acute cellular rejection. Failure to
mprove strains was associated with a higher inci-
ence of death and cardiac events. We further
nvestigated the determinants of persistent allograft
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996V dysfunction at 1 year and found that the gene
xpression score used to characterize host alloim-
une responses was the only independent predictor
f global LV LS, independent of the presence of
ardiac rejection, allograft vasculopathy, and other
linical variables. However, contrary to logical ex-
ectations, the gene expression score was positively
0
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    Group A 31 16 
    Group B 11 10 
Figure 5. Kaplan-Meier Curve for Outcome of Death or Hospital
Heart transplantation patients with unchanged or reduced global lo
combined end point (hazard ratio: 5.92; 95% conﬁdence interval: 1.
of global LS at 3 months (group B).
Table 5. Univariate and Multivariate Analysis Results:
Outcome Global Longitudinal Strain
Predictor Estimate SE p Value
Univariate
Gene expression score 0.47 0.10 0.001
EF 0.18 0.07 0.02
LV mass 0.04 0.01 0.005
LVDs 0.36 0.17 0.05
CO (l/min) 1.10 0.55 0.06
E= medial 57.83 31.86 0.09
E/E= medial 0.18 0.10 0.08
Multivariate
Gene expression score 0.41 0.13 0.005
EF 0.009 0.08 0.12
LV mass 0.03 0.01 0.07
Variables tested in univariate analysis and not found to be signiﬁcant were
age, biopsy grade, history of hypertension, diabetes, hyperlipidemia, obstruc-
tive sleep apnea, body mass index at baseline and 12 months, serum
creatinine at baseline and 12 months, B-type natriuretic peptide at baseline
and 12 months, cytomegalovirus positivity, coronary allograft vasculopathy,
right atrial pressure, right ventricular systolic pressure, pulmonary capillary
wedge pressure, mixed venous oxygen saturation, CO and cardiac index,
interventricular septal thickness, LV diastolic dimensions, left atrial volume
index, mitral E and A velocities, E/A ratio, deceleration time, isovolumic
relaxation time, E= lateral annulus, E/E= lateral annulus, stroke volume,
tricuspid regurgitant jet peak velocity, and tricuspid valve maximum instan-
taneous gradient.
Abbreviations as in Table 3.orrelated with LV LS, and this relationship ap-
eared to be driven primarily by SEMA7A gene
xpression. We also observed a trend toward a
ignificant relationship between LV mass and
lobal LS at 12 months, as shown in Table 5.
V function in patients with TXH. The burden of LV
ysfunction that evolved in patients with TXH,
ndependent of biopsy-detected cellular rejection in
he present study, is consistent with a previous
nvestigation in which the scintigraphic evidence of
yocardial injury exceeded that seen in endomyo-
ardial biopsy specimens (31). Indeed, the individ-
al variability of the course of rejection is striking:
ome patients acquire tolerance to grafts as early as
months after transplantation; in others, this pro-
1095 1460 1825
Days
Group B
(LS Improved)
Group A
(LS Unchanged or Reduced)
 5 3 1
 4 0 0
ion for Heart Failure or Rejection
tudinal strain (LS) at 3 months (group A) had a higher risk for the
o 17.91; p  0.049) compared with those who had improvement
Table 6. Relationship of Global LS With Individual
Gene Expression
Gene r Value p Value
IL1R2 0.27 0.20
FLT3 0.04 0.80
ITGAM 0.35 0.90
ITGA4 0.33 0.10
PF4 0.33 0.11
C6orf25 0.41 0.04
PDCD1 0.41 0.02
MIR 0.19 0.36
WDR40A 0.16 0.45
SEMA7A 0.84 0.001
RHOU 0.09 0.65730
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997ess might not develop until the third or fourth year
fter the operation. Up to one-third of patients who
ndergo transplantation who survive more than 5
ears show smoldering rejection and never develop
olerance to their grafts (32). Several groups have
eported detection of rejection-related myocardial
amage through myocardial uptake of indium-111-
abeled monoclonal antimyosin antibodies (33–36).
n these studies, hearts that showed decreases of
ntibody uptake during the first 3 months after
ransplantation appeared to be free from severe
ejection-related complications during the first year,
hereas persistent antimyosin uptake during the
rst 3 months indicated a higher risk for such
omplications during that interval (34). Corre-
pondingly, in our study, those subjects without
mprovements in global LS at 3 months after
ransplantation had a higher rate of complications,
ncluding death, rejection, and heart failure.
To overcome the uncertainty in assessing LV
echanical function in patients with TXH, several
ovel echocardiographic markers have been de-
cribed. However, the enthusiasm in using these
ndexes, including Doppler- and tissue Doppler–
erived indexes of LV mechanical performance, in
atients with TXH has been marred by discordant
esults in different investigations (37,38). Little is
nown, however, about the spectrum of changes in
V mechanical function in patients with TXH
sing speckle-tracking strain echocardiography. A
revious study suggested that regional strains were
ttenuated in the basal and mid-lateral walls of the
V in patients with TXH with more than Interna-
ional Society for Heart and Lung Transplantation
rade 1B rejection; however, considerable overlap
as seen, particularly for strain values obtained
rom the LV septum, where LS was equally atten-
ated in all patients with TXH (39,40). Our study
uggests that patients with TXH have a substantial
urden of LV regional and global dysfunction
ithin the first 2 years, and these unique cumulative
hanges in LV mechanical function evolve indepen-
ent of changes due to clinically detectable trans-
lant rejection. Global LS has now emerged as an
ccurate predictor of clinical outcomes, including
ll-cause mortality, in the nontransplantation pop-
lation (41). In our study of cardiac transplantation
atients, changes in global LS similarly were asso-
iated with death and cardiac events, including
ejection and heart failure.
ene expression proﬁles correlate with LV mechanical
unction. The gene expression score is a 20-gene
eal-time polymerase chain reaction assay that pro- suces a gene expression signature that has been
hown to correlate with biopsy-defined rejection
20). In the Cardiac Allograft Gene Expression
bservational study (26), to date the largest and
ost systematic investigation of gene expression
core for the diagnosis of heart graft rejection, the
se of a diagnostic score threshold favoring negative
redictive value was estimated to have a negative
redictive value of 99.6%, a positive predictive value
f 6.8%, sensitivity of 88.9%, and specificity of
9.4% for detecting grade 3A rejection. An in-
eresting feature of the Cardiac Allograft Gene
xpression Observational data was that grade 1B
ndomyocardial biopsy samples were associated
ith gene expression scores similar to those of grade
3A samples and significantly higher than those of
rade 2 samples (as well as grades 1A and 0)
26,42). Considering the diversity of genes incor-
orated into the gene expression score, it is con-
eivable that their individual and cumulative acti-
ations may serve a variety of purposes beyond
daptive immunological activation.
Upon examination of specific genetic subcompo-
ents of the gene expression score, we found that
EMA7A had the strongest correlation with aver-
ged global LS at 1 year. Semaphorins constitute a
arge family of secreted and membrane-tethered cell
ignaling molecules with functions in neural devel-
pment, macrophage and T-cell activation path-
ays, cardiac growth, and vascular development
43,44). Although semaphorins were initially incor-
orated into the AlloMap gene expression score for
heir possible role in acute cellular rejection, the
resent study raises the possibility that their other
athways may be associated with graft function.
nalysis from the Cardiac Allograft Gene Expres-
ion Observational study revealed that SEMA7A
xpression increased in a time dependent manner
eyond 6 months after transplantation. The exact
eason for this was not clear, and it was suggested
hat intrinsic or extrinsic factors that vary by time
fter transplantation may alter the peripheral mo-
ecular signatures of peripheral blood mononuclear
ells in heart transplant recipients. Several possibil-
ties exist for explaining the relationship of SEMA
ith LV longitudinal mechanics in patients with
XH. Notably, semaphorins modulate sympathetic
einnervation patterning (43) and cardiac regional
ontractility (45,46), variables that may be associ-
ted with improved exercise tolerance in patients
ith cardiac transplantation at 1 year (47,48).
linical implications. After cardiac transplantation,
ignificant efforts are directed toward the identifi-
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998ation and prevention of acute cellular rejection and
oronary allograft vasculopathy in heart transplant
ecipients (14). Our data emphasize the need to
ecognize the presence of substantial LV dysfunc-
ion in patients with TXH that evolves independent
f clinically detectable acute cellular rejection or
llograft vasculopathy that correlates with long-
erm clinical outcomes. Although LV ejection frac-
ion is widely used in transplantation practice to
ake clinical decisions, our data suggest that the
ssumptions in the range and variability of LV
unction on the basis of ejection fraction may not be
alid. Rather, regional and global LV mechanics
uantified by novel techniques such as speckle-
racking echocardiography may serve as robust bi-
markers. The novel relationship between gene
xpression profile, LV mechanics, and the impact
n overall graft survival needs further exploration.
articularly, the role of SEMA7A gene requires
uture consideration as a potential molecular target
or gene therapy (49) in chronic graft dysfunction.
tudy limitations. Although the present study has
dentified a relationship between LV mechanics and
eripheral blood mononuclear cell gene expression
cores, the heart surface was not directly examined
or the presence of these markers to establish the
efinite pathways. Furthermore, LV torsional me-
hanics were not investigated in this study, because
f nonavailability of optimal cross-sectional views of
he LV apex in the immediate post-transplantation
eriod. Variability in CS and RS was higher than in
S, a finding that concurs with reproducibility data
rom a previous study (50). This may be due tode Werf F, Sutherland GR, Suetens
P. Echocardiographic strain and parison with cardiracking data obtained in short-axis views. Future
tudies with 3-dimensional speckle tracking may be
seful for confirming the observed relationships.
he AlloMap gene expression score has been vali-
ated in the transplantation population; under-
tanding its use and relationship with myocardial
echanics in the nontransplantation population
ill require further investigation.
ONCLUS IONS
peckle tracking–derived LV strains are helpful in
stimating the burden of LV dysfunction in patients
ith TXH that evolves independent of biopsy-
etected cellular rejection. Failure to improve global
S at 3 months after transplantation is associated with
higher incidence of death and cardiac events. Serial
hanges in LV mechanics correlate with peripheral
lood gene expression profiles and may affect clinical
ssessment of long-term prognosis in patients with
XH.
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